{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:59:11Z","timestamp":1790441951443,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.eplepsyres.2026.107926","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:22:12Z","timestamp":1790205732000},"page":"107926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond the classic ketogenic diet: A systematic review of alternative and adjunctive therapies for GLUT1 deficiency syndrome"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4482-3506","authenticated-orcid":false,"given":"Raffaele","family":"Falsaperla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Ben Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Sortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.eplepsyres.2026.107926_bib1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/dmcn.13167","article-title":"Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome","volume":"58","author":"Amalou","year":"2016","journal-title":"Dev. Med. Child. Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2026.107926_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00415-010-5702-5","article-title":"Excellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency","volume":"258","author":"Anheim","year":"2011","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107926_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejpn.2019.02.012","article-title":"Failure of ketogenic diet therapy in GLUT1 deficiency syndrome","volume":"23","author":"Bekker","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"8","key":"10.1016\/j.eplepsyres.2026.107926_bib4","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/mds.29822","article-title":"Triheptanoin did not show benefit versus placebo for the treatment of paroxysmal movement disorders in Glut1 deficiency syndrome: results of a randomized phase 3 study","volume":"39","author":"De Giorgis","year":"2024","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.eplepsyres.2026.107926_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199109053251006","article-title":"Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay","volume":"325","author":"De Vivo","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2026.107926_bib6","article-title":"Modified Atkins Diet with slow reduction of carbohydrate","volume":"13","author":"Gauthier","year":"2019","journal-title":"Epilepsy Behav. Rep."},{"key":"10.1016\/j.eplepsyres.2026.107926_bib7","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/jnnp-2018-320283","article-title":"Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect","author":"Hainque","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry Vol. 9011"},{"issue":"9","key":"10.1016\/j.eplepsyres.2026.107926_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.braindev.2020.05.010","article-title":"Glucose transporter type 1 deficiency syndrome associated with autoantibodies to glutamate receptors","volume":"42","author":"Hoshino","year":"2020","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107926_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.braindev.2007.08.006","article-title":"Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome","volume":"30","author":"Ito","year":"2008","journal-title":"Brain Dev."},{"issue":"7","key":"10.1016\/j.eplepsyres.2026.107926_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1469-8749.2011.03961.x","article-title":"A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome","volume":"53","author":"Ito","year":"2011","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.eplepsyres.2026.107926_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.seizure.2016.01.011","article-title":"Use of dietary therapies amongst patients with GLUT1 deficiency syndrome","volume":"35","author":"Kass","year":"2016","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107926_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.eplepsyres.2011.02.007","article-title":"GLUT1 deficiency syndrome in clinical practice","volume":"100","author":"Klepper","year":"2012","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107926_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70044","article-title":"Glut1 Deficiency syndrome: novel pathomechanisms, current concepts, and challenges","volume":"48","author":"Klepper","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107926_bib14","first-page":"354","article-title":"Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open","volume":"5","author":"Klepper","year":"2020"},{"issue":"9","key":"10.1016\/j.eplepsyres.2026.107926_bib15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/genes12091379","article-title":"GLUT1 Deficiency syndrome-early treatment maintains cognitive development? (Literature Review and Case Report)","volume":"12","author":"Kolic","year":"2021","journal-title":"Genes"},{"issue":"Pt 3","key":"10.1016\/j.eplepsyres.2026.107926_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/brain\/awp336","article-title":"Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder","volume":"133","author":"Leen","year":"2010","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.eplepsyres.2026.107926_bib17","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/acn3.51462","article-title":"Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome","volume":"8","author":"Logel","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107926_bib18","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1038\/s41598-023-30578-z","article-title":"Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D)","volume":"13","author":"M\u00e1laga","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.eplepsyres.2026.107926_bib19","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1111\/epi.17684","article-title":"A concise study of acetazolamide in glucose transporter type 1 deficiency (G1D) epilepsy","volume":"64","author":"M\u00e1laga","year":"2023","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2026.107926_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jnnp-2015-311475","article-title":"Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency","volume":"87","author":"Mochel","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2026.107926_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejpn.2023.05.005","article-title":"Uncommon use of intermittent glucose administration for infrequent non-epileptic paroxysmal events in GLUT1-DS","volume":"45","author":"Mortaji","year":"2023","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107926_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pediatrneurol.2013.09.002","article-title":"A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia","volume":"50","author":"Ohshiro-Sasaki","year":"2014","journal-title":"Pediatr. Neurol."},{"issue":"10","key":"10.1016\/j.eplepsyres.2026.107926_bib23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jamaneurol.2014.1584","article-title":"Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement","volume":"71","author":"Pascual","year":"2014","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2026.107926_bib24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/nu13030840","article-title":"Pedr\u00f3n-Giner C. Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases","volume":"13","author":"Ruiz Herrero","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.eplepsyres.2026.107926_bib25","article-title":"Treatment of an Opposing Metabolic Situation: GLUT1-Deficiency Syndrome and Type 1 Diabetes","volume":"66","author":"Schoenlaub","year":"2025","journal-title":"JIMD Rep."},{"issue":"7","key":"10.1016\/j.eplepsyres.2026.107926_bib26","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/epi.17263","article-title":"A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndrome","volume":"63","author":"Striano","year":"2022","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107926_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpn.2015.09.008","article-title":"Lactate and its many faces","volume":"20","author":"Taher","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2026.107926_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2008.03.010","article-title":"Molecular analysis and anticonvulsant therapy in two patients with glucose transporter 1 deficiency syndrome: a successful use of zonisamide for controlling the seizures","volume":"80","author":"Takahashi","year":"2008","journal-title":"Epilepsy Res."},{"issue":"9","key":"10.1016\/j.eplepsyres.2026.107926_bib29","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/acn3.50881","article-title":"Therapeutic strategies for glucose transporter 1 deficiency syndrome","volume":"6","author":"Tang","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2026.107926_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-2134-8766","article-title":"Effects of sodium lactate infusion in two girls with glucose transporter 1 deficiency syndrome","volume":"54","author":"van Gemert","year":"2023","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.eplepsyres.2026.107926_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11940-014-0291-8","article-title":"Dietary treatments and new therapeutic perspective in GLUT1 deficiency syndrome","volume":"16","author":"Veggiotti","year":"2014","journal-title":"Curr. Treat. Options Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2026.107926_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12519-024-00864-5","article-title":"Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome","volume":"21","author":"Zhang","year":"2025","journal-title":"World J. Pediatr."},{"issue":"6","key":"10.1016\/j.eplepsyres.2026.107926_bib33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/MOP.0000000000001170","article-title":"Updates on the diagnostic evaluation, genotype-phenotype correlation, and treatments of genetic epilepsies","volume":"34","author":"Zimmern","year":"2022","journal-title":"Curr. Opin. Pediatr."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126001968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126001968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:29:20Z","timestamp":1790440160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121126001968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0920121126001968"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107926","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the classic ketogenic diet: A systematic review of alternative and adjunctive therapies for GLUT1 deficiency syndrome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107926"}}